用户名: 密   码:
注册 | 忘记密码?
专利信息
查询条件 展开筛选条件
  • [专利权人] 包含 'SQUIBB BRISTOL MYERS CO [US]'
  • [药品] 包含 'Troglitazone'
排序 翻到页码
标题标题2专利权人发明人附图摘要摘要2优先权号IPC专利类型
首页12尾页18 条记录, 当前第1/2页。
公开号 公开日 申请号 申请日
1. US7390824B1 2008/6/24 US19990391053 1999/9/7
专利标题:Method for treating diabetes employing an aP2 inhibitor and combination 法律状态
A method is provided for treating diabetes and related diseases, especially Type II diabetes, employing an aP2 inhibitor or a combination of an aP2 inhibitor and another antidiabetic agent such as metformin, glyburide, troglitazone and/or insulin.


2. KR20060026125A 2006/3/22 KR20067004515 2006/3/3
专利标题:CYCLOPROPYL-FUSED PYRROLIDINE-BASED INHIBITORS OF DIPEPTIDYL IV, PROCESSES FOR THEIR PREPARATION, AND THEIR USE 法律状态
Dipeptidyl peptidase IV (DP 4) inhibiting compounds are provided having the formula (I) where x is 0 or 1 and y is 0 or 1 (provided that x = 1 when y = 0 and x = 0 when y = 1)


3. EP1559710A2 2005/8/3 EP20050005368 2001/3/5
专利标题:Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV, process for their preparation and their use 法律状态
Dipeptidyl peptidase IV (DP 4) inhibiting compounds are provided having the formula (I) where x is 0 or 1 and y is 0 or 1 (provided that x = 1 when y = 0 and x = 0 when y = 1)


4. WO03043624A1 2003/5/30 WO2002US36580 2002/11/15
专利标题:DUAL INHIBITORS OF ADIPOCYTE FATTY ACID BINDING PROTEIN AND KERATINOCYTE FATTY ACID BINDING PROTEIN 法律状态
Compounds that are dual aP2/k-FABP inhibitors are provided having the formula (I), wherein A, B, X, Y, R<1>, R<2> and R<3> are as described herein. A method is also provided for treating diabetes and related diseases, especially Type II diabetes, employing dual aP2/k-FABP inhibitors alone or in combination with at least one other antidiabetic agent such as metformin, glyburide, troglitazone and/or insulin.


5. US6548529B1 2003/4/15 US20000519079 2000/3/6
专利标题:Heterocyclic containing biphenyl aP2 inhibitors and method 法律状态
aP2 inhibiting compounds are provided having the formulawherein R1, R2, R3, R4, X-Z andare as described herein.A method is also provided for treating diabetes and related diseases, especially Type II diabetes, employing such aP2 inhibitor or a combination of such aP2 inhibitor and another antidiabetic agent such as metformin, glyburide, troglitazone and/or insulin.


6. WO03006023A1 2003/1/23 WO2002US22186 2002/7/12
专利标题:PYRAZINONE INHIBITORS OF FATTY ACID BINDING PROTEIN AND METHOD 法律状态
aP2 inhibiting compounds are provided having the formula [I] wherein A, X, R and Z are as described herein. A method is also provided for treating diabetes and related diseases, especially Type II diabetes, employing such aP2 inhibitors alone or in combination with other therapeutic agents, including other antidiabetic agent such as metformin, glyburide, troglitazone and/or insulin.


7. WO02083128A1 2002/10/24 WO2002US10936 2002/4/5
专利标题:2,1-OXAZOLINE AND 1,2-PYRAZOLINE-BASED INHIBITORS OF DIPEPTIDYL PEPTIDASE IV AND METHOD 法律状态
Dipeptidyl peptidase IV (DP 4) inhibiting compounds are provided having the formula where n is 0 or 1


8. CA2444465A1 2002/10/24 CA20022444465 2002/4/5
专利标题:2,1-OXAZOLINE AND 1,2-PYRAZOLINE-BASED INHIBITORS OF DIPEPTIDYL PEPTIDASE IV AND METHOD 法律状态
Dipeptidyl peptidase IV (DP 4) inhibiting compounds are provided having the formula where n is 0 or 1


9. WO0240448A1 2002/5/23 WO2001US43647 2001/11/20
专利标题:PYRIDONE DERIVATIVES AS AP2 INHIBITORS 法律状态
aP2 inhibiting compounds are provided having the formula wherein A, Q, and X are as described herein. A method is also provided for treating diabetes and related diseases, especially Type II diabetes, employing such aP2 inhibitor or a combination of such aP2 inhibitor and another antidiabetic agent such as metformin, glyburide, troglitazone and/or insulin.


10. CA2436854A1 2002/5/23 CA20012436854 2001/11/20
专利标题:PYRIDONE DERIVATIVES AS AP2 INHIBITORS 法律状态
aP2 inhibiting compounds are provided having the formula wherein A, Q, and X are as described herein. A method is also provided for treating diabetes and related diseases, especially Type II diabetes, employing such aP2 inhibitor or a combination of such aP2 inhibitor and another antidiabetic agent such as metformin, glyburide, troglitazone and/or insulin.



首页12尾页18 条记录, 当前第1/2页。

下载范围

下载第 条记录。

下载内容

题录信息 专利全文